Estrogen receptor‐α36 is involved in development of acquired tamoxifen resistance via regulating the growth status switch in breast cancer cells
Guangliang Li(Zhejiang Cancer Hospital), Lisong Teng(First Affiliated Hospital Zhejiang University)
Cited by 73
Related Papers
COL12A1, a novel potential prognostic factor and therapeutic target in gastric cancer
|Molecular Medicine Reports|2019|66
GPRC5A: An Emerging Biomarker in Human Cancer
|BioMed Research International|2018|46
Diagnostic value of BRAFV600E-mutation analysis in fine-needle aspiration of thyroid nodules: a meta-analysis
|OncoTargets and Therapy|2016|34
VCAM-1 Upregulation Contributes to Insensitivity of Vemurafenib in BRAF-Mutant Thyroid Cancer
|Translational Oncology|2020|18
BP‑1‑102 exerts an antitumor effect on the AGS human gastric cancer cell line through modulating the STAT3 and MAPK signaling pathways
|Molecular Medicine Reports|2019|12